Skip to main content
. 2008 Jul 19;58(3):373–381. doi: 10.1007/s00262-008-0560-z

Fig. 1.

Fig. 1

Survival of vaccinated mice after subcutaneous challenge with RM-9 cells. Mice were vaccinated with 1 × 106 γ-irradiated cells or PBS. Vaccines were administered once a week for three consecutive weeks, followed by a challenge of RM-9 cells in the fourth week. Tumor size was measured in time and survival determined (* P < 0.05 compared to the RM-9 vaccinated group)